chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my shot at 1:52 pm.  Around 10:00 pm I suddenly had terrible tinnitus  in my right ear.  It was more severe than any ear ringing I have ever experienced. It got worse and then better and then worse on and off for about 2 hours. At that point the ear ringing got better and was similar to general ear ringing I have experienced. I have only experienced bad ear ringing once (actually in my left ear) since then. I also had dark purple nickel sized bruise at the injection site that took 2 weeks to heal. I did not seek medical treatment for the ear ringing and I assume that the issue has resolved itself.
Narrative: no reaction reported. vaccine incorrectly documented, wrong manufacturer charted. Documentation corrected
Pt started feeling itchy and dryness to the throat. Patient also felt as if her tongue was swelling. Admin of Zyrtec 10mg ODT and Albuterol 90mcg (4puffs)). Patient stated all symptoms resolved within 3-5 minutes post medication administration. Patient was kept under observation for approximately 45 minutes.
had some pain in his arm; fever of 101 degrees Fahrenheit; felt sick all night; felt some chills; This is a initial spontaneous report received from a contactable consumer. A 65-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number and expiration date were not reported) via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunisation. Medical history included some heart problem ongoing (underlying condition). The patient's concomitant medications were not reported. After receiving the immunisation, the patient experienced fever of 101 degrees Fahrenheit (Body temperature), felt sick all night, felt some chills, no nausea, also had some pain in his arm. Patient had some underlying condition like heart problem. The outcome for all the events were unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Swollen lymph node above clavicle near acromion on  same side as injection site - no other symptoms to indicate other underlying health issue
Patient has reported redness, swelling, and itching at injection site.  She was informed to use a cold compress to help alleviate symptoms and to use generic Benadryl if itching is too bothersome.
Within hours, I was extremely fatigued.  Within a day or two, I began experiencing a dry, hacking cough.  These symptoms persisted and have grown worse over the past 3 1/2 weeks.  I was seen for emergency visits where I was having difficulty breathing, and was prescribed an albuterol inhaler.  Even with treatment, I am unable to sleep due to coughing and feel very ill.
Fatigue, muscle aches, headache, nausea and continuing pain in right jaw joint
Spontaneous Abortion. Miscarriage started on it's own at home.  Bleeding lasted 14 days, then turned to excessive hemorrhaging and ended up getting an emergency D&C. Was 10 weeks pregnant at time of miscarriage. EDD was 10/23/2021.
Four days after my booster dose of the COVID vaccine, I noticed myself rubbing my arm a few inches below the injection site. There was a lump, soreness, warmth, and red skin in the area, lasting more than two weeks. I now suspect, after experiencing additional chest pain symptoms, that it might have been deep vein thrombosis. While the soreness at the injection site faded within a few days of receiving the vaccine booster, the lump further down arm my lasted longer and included changes in my skin. To the touch, my skin felt like crepe paper, and I had two small sores. All arm symptoms have now healed, one month later. Additional chest pain has been alleviated with daily low-dose aspirin regimen and walking.
Patient complained of weak, tingly arm, then upon returning home from clinic put her pajamas on and went to bed stating she felt tired.  Mom states she is irritable and crying.
Flushed cheeks, splotchy rash, erythematous legs, and vomiting.  Also occurred after first dose of Augmentin. Difficult to tell if vaccine reaction, medication reaction, or viral symptoms as he had OM at the time and URI sx. No fevers and was not acting ill.
Patient reported unusually high heart rate for him starting the morning after the vaccine and lasting about 8 hours. Patient reported that he self monitored and his blood pressure remained normally but his normally low heart rate exceeded 100. He almost went to the Emergency Room but decided against it as the heart rate eventually dropped down the same day.
Pain in upper arm at shot site has continued and getting worse.   It has affected range of motion, strength, and is causing me pain.  Whenever I lay on the arm, it hurts.  Whenever I reach for something (like a cup of coffee), it hurts.  I saw an orthopedic who x-rayed it, said that the shot probably hit a bursa and caused bursitis, and recommended either steroid injection or PT.  I have chosen to try acupuncture first.  It continues to be painful at this time whenever I have to use the left arm.  It isn't clear if anything will permanently correct this problem, so I do not know if it is a permanent disability or not.
Patient may have been given an expired vaccine. Sibling was vaccinated at the same time, no way of knowing who got the expired vaccine.
No adverse affects reported; improperly stored VARIVAX was administered to patient; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/ allergies were not reported.  On 07-MAY-2020 the patient was vaccinated with improperly stored of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # S012036, expiration date 17-APR-2020; dose, frequency and route were not reported) for prophylaxis (product storage error).        The administered dose of the vaccine experienced a temperature 48.2 for 2 hours. There was no previous temperature excursion. The digital data logger was involved. No adverse effects were reported.
Date removed from freezer 8/22/22 . Thaw expiration date 9/21/22 @0800. Dose administered 9/22/22. Doses administered after 30 day thaw expiration. Moderna was contacted for assessment of vaccine activity for both doses. Based on the assessment vaccine maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration per Moderna.  No adverse events reported
Approximately 3 minutes after her injection, the patient experienced stomach pain, hot flashes, and pallor so was taken to our roof for fresh air. While being escorted by parent and staff, the patient fainted and was supported to the ground. Epinephrine was administered and 911 was called. Paramedics arrived shortly thereafter and examined patient. Patient was cleared by paramedics and walked out of the clinic unassisted.
Muscle weakness; Muscle pain; Fever; severe fatigue; Sore throat; brand=Pfizer / prev dose brand=Moderna; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Oct2022 as dose 5 (booster), single (Lot number: GH9703) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna (dose 4, administered in the right arm at 12:00, Lot number: 025L2B), administration date: Apr2022, when the patient was 63 years old, for Covid-19 immunization; Moderna (dose 3, administered in the right arm at 12:00, Lot number: 065F21A), administration date: Nov2021, when the patient was 63 years old, for Covid-19 immunization; Moderna (dose 2, administered in the right arm at 12:00, Lot number: 006C21A), administration date: May2021, when the patient was 62 years old, for Covid-19 immunization; Moderna (dose 1, administered in the right arm at 12:00, Lot number: 040B21A), administration date: Apr2021, when the patient was 62 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 10Oct2022, outcome "not recovered", described as "Fever"; MYALGIA (non-serious) with onset 10Oct2022, outcome "not recovered", described as "Muscle pain"; MUSCULAR WEAKNESS (non-serious) with onset 10Oct2022, outcome "not recovered", described as "Muscle weakness"; OROPHARYNGEAL PAIN (non-serious) with onset 10Oct2022, outcome "not recovered", described as "Sore throat"; FATIGUE (non-serious) with onset 10Oct2022, outcome "not recovered", described as "severe fatigue"; INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset Oct2022, outcome "unknown", described as "brand=Pfizer / prev dose brand=Moderna". Therapeutic measures were not taken as a result of muscular weakness, myalgia, pyrexia, fatigue, oropharyngeal pain.
Patient received SHINGRIX on 04/12/2019 and came to the pharmacy counter on 4-24-19 and reported the adverse event. Patient stated redness along arm vaccine was given in as well as down to the breast and back. Patient was seen by a doctor and informed us the doctor diagnosed the patient shingles.
Due to a look-alike sound-alike error, Moderna Booster vaccine was administered instead of Moderna Bivalent vaccine. The Moderna Booster packaging was labeled "Booster" with no indication of whether it was bivalent or monovalent. Vials had blue caps similar to the bivalent vials. This packaging was sent after the local authority annouced that only bivalent could be used for booster doses. No adverse events or side effects reported. Mistake detected 12/14/2022.
Within minutes of receiving vax pt experienced tingling in her left arm which then moved to her left leg. Pt stated that the tingling localized in her left leg at the site of a previous injury and that she experienced pain in this area. Pt was unable to walk for a couple of days due to pain and then needed a cane for a couple of weeks. She stated that her leg is now weaker and that experiences pain in the area of a previous injury and that her pre-existing limp is now more pronounced.
Patient fainted while in observation area, her mother assisted her to the ground. Within seconds patient came to and was responding verbally We placed her on a mat,gave a cold compress and elevated her legs Ems was contacted, came and evaluated and no treatment was determined to be given. Mother deferred transportation further evaluation we returned her to the chair where she was observed for more time. She then left with her mother ambulatory on her own.
Within 5 minutes of receiving the shot she started coughing/gagging , her face and neck became flushed, and she started developing hives on her cheeks. Pharmacist brought liquid diphenhydramine oral solution and I administered 2.5 ml (6.25 mg), which she drank. Symptoms resolved within 10 minutes. Out of an abundance of caution, I took her to a nearby pediatric urgent care where the pediatrician confirmed that the allergic reaction had resolved.  She has never had an allergic reaction to a vaccine or immunization. She is up to date on all immunizations and this was her 4th covid vaccine. Prior covid vaccines were all Pfizer: primary series administered on 6/22/22, 7/13/22, 9/7/22; bivalent booster administered on 11/3/22
Information has been received from a lawyer regarding a case in litigation concerning an approximately 54 year old female. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 12-APR-2017, the patient was administered the ZOSTAVAX by a health care provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a health care provider for the following injury resulting from her use of ZOSTAVAX: shingles. The patient claims damages as a result of: injury to herself, loss of consortium, loss of services, and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
Inflammation of heart; Significant amount of blood clots in both lobes of lungs; Inflammation of lungs; This is a spontaneous report from a contactable consumer (Daughter). An 85-years-old male patient received bnt162b2 (BNT162B2), dose 2 on Apr2021 (Batch/Lot number was not reported) at 85-year-old as DOSE 2, SINGLE for covid-19 immunisation. Medical history was none. There were no concomitant medications.  The patient previously received first dose of bnt162b2 (MANUFACTURER UNKNOWN), dose 1 on unknown date in Apr2021 (Batch/Lot Number: Unknown) at age of 85-year-old for covid-19 immunisation. Events occurred within a few days after the second dose in Apr2021. Started off with inflammation of the heart, inflammation of the lungs.  There was a significant amount of blood clots in both lobes of patient's lungs. Patient was put on blood thinners after the discovery of the blood clots. Patient has been started on Eliquis. Needs blood thinners for rest of life. The outcome was recovering.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Severe chills, fever of 103 degrees Fahrenheit, joint pain, severe headache, body aches
p/vax pt devel h/a, dizziness;sx mostly resolved by 9/29/99;
pt recvd vax;fever of 105;to md,recommended fever reducing measures at home & apap; to MD next day had Rt acute OM;started ATB; low grade t still present @ 4pm on 9dec94;
Anaphylaxis; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had anaphylaxis from the Covid 19 vaccine.  It was reported that I'm trying to figure out what caused it, so people in my family with similar allergies know whether or not it is safe for them. I have never had anaphylaxis from any other vaccine in my life. I believe very much in vaccines. Now I know that usually my worst anaphylaxis is from artificial sweeteners, such as sucralose, aspartame, and saccharine. The outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This spontaneous report was received from a doctor of pharmacy concerning an unspecified number of patients of unknown age and gender. It was reported that on an unknown date, an unspecified number of patient may have vaccinated with a dose of VAQTA (lot number, expiry date, dose and route unspecified) which was exposed to 10 degrees Fahrenheit (F) for 8 hours, which was an excursion that was unsupported by in-house stability data. No concomitant medications were reported. No adverse symptoms were reported. This is one of the two reports from the same source. Additional information has been requested.
Pt. returned to pharmacy on 10/1/13. (L) arm swollen, red, warm to touch. Pt. instructed to seek medical attention from walk-in clinic.
Received 2nd dose of moderna vaccine 2/5/21 .  That night i had high fevers nausea and myalgias. Starting 2 days after second dose i have had oral burning and tooth pain.  Presented to city md had covid testing done which was negaitve,The roof of my mouth burns as well as my gums, tongue and sometimes lips.  I have seen multiple doctors including ENT, dentist, infectious disease and spoken with the NIH, This is all day every day.  Im currently taking neurontin,l-lysine,alpha lipoic acid,prevacid, vitamin d , klonopin none of which are helping.
patient got flu; Initial information was received on 01-Dec-2020 regarding an unsolicited valid non-serious case from a social media via consumer or non-health care professional (Patient).  This case involves patient (age and gender unspecified) who experienced flu (influenza), while patient received INFLUENZA VACCINE, [Flu shot].   Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) unknown latency following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the lot number for this case.
Covid vaccine on 1/19. Took Enbrel injection for RA on 1/19 evening. On 1/21, pt experienced diarrhea. Has had diarrhea after Enbrel before, but not to this degree.
severe respiratory distress; coughing; shakes; chills; massive diarrhea and vomiting; massive diarrhea and vomiting; scared to get the 2nd dose; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown), via an unspecified route of administration on 13Mar2021 09:30 as SINGLE DOSE for covid-19 immunisation, age at vaccination unknown. The patient medical history and concomitant medications were not reported. Patient reported that she got the 1st dose on 13March2021 at 09:30 AM. She experienced "real bad side effects: severe respiratory distress, coughing, to the point her husband almost called to take her to the hospital. Next morning, she reported shakes, chills, massive diarrhea and vomiting. Patient reported she is scared to get 2nd one.  She commented, "I heard through the grapevine some people have nothing after 1st one and have something after 2nd one". Outcome of the events was unknown.  Information on Lot/Batch number has been requested.
12/06/21 presents to FBC for "". PMHx of "Decrease fetal movement / Covid positive / non-productive cough/ weakness". "No pertinent past medical history"
seizure; This is a spontaneous report from a Pfizer-sponsored program. A non-Contactable consumer (patient) reported that a male patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) (at the age of unknown) as dose 2, single for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient previously received BNT162b2 as dose 1 at an unknown age for COVID-19 immunisation and experienced flu like symptoms. After his second shot of the vaccine, he had a seizure and ending up in the hospital.  Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a healthcare professional concerning a female patient who received a dose of flu-Shield (influenza virus vaccine, trivalent, types A & B 2002-2003 formula) on 23-OCT-2002.  On 24-OCT-2002, one day post-immunization, the patient developed an injection site reaction which consisted of "massive discoloration" extending "from the injection site to the elbow of the affected arm".  The patient went to the emergency room.  the reporter had no further information at the date of this report.
Two hours after vaccination arm started hurting and feeling heavy.  Arm started itching and hour after she became tired and very sleepy.  Arm then started swelling, itching with a red rash.  She started having issues breathing, hands became swollen and tingling.  Arm currently has a hard lump at injection sight, hurts if pressed on and discoloration is there.
She had broken out with shingles on her foot; Her leg started to get really achy; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (She had broken out with shingles on her foot) and PAIN IN EXTREMITY (Her leg started to get really achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (She had broken out with shingles on her foot) and PAIN IN EXTREMITY (Her leg started to get really achy). At the time of the report, HERPES ZOSTER (She had broken out with shingles on her foot) and PAIN IN EXTREMITY (Her leg started to get really achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I started out with horrible stomach cramps, then diarrhea, throwing up, 101 degree fever with chills. On Sunday the fever went to 97, then other than fatigue I felt fairly good. My doctor's office asked me to test and I found I was positive. I was prescribed PAXLOVID and I took it for 5 days.
Started soreness at injection site, bad headache, drippy nose, sore swollen lymph nodes , aches, feeling of weakness, generally weak, feeling bad.
administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. Vial did not undergo temperature excursion.  Total of 168 doses were given from LOT 048B21A. No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live non significant follow up. No new clinically significant information received.
patient had pain on first dose and has been experiencing pain in the left arm and increased after getting second dose of hepatitis B, patient has taking  Tylenol  as needed